Should Viking (VKTX) Stock be in Your Portfolio Pre-Q2 Earnings?

Viking's loss estimates have increased from $1.08 per share to$1.11 for 2024 and from $1.42 to$1.45 for 2025 in the past 60 days. Zacks Investment Research Surprise - Reported Earnings History 0 Earnings Whispers Without an approved/marketed product in its portfolio, the focus is expected to be on updates related to Viking's pipeline consisting of three candidates — VK2735 (for obesity), VK2809 (for non-alcoholic steatohepatitis [NASH]) and VK0214 (for X-linked adrenoleukodystrophy (X-ALD)]. Viking Therap ...